Mesoblast logo
MSBMesoblast
Trade MSB now
Mesoblast primary media

About Mesoblast

Mesoblast (ASX:MSB) is an Australian cell therapy company focused on the development and commercialization of cell therapy products for a range of diseases. The company's operations are focused on the manufacturing of cell therapy products, clinical trials of cell therapy products, regulatory approval of cell therapy products, and commercialisation of cell therapy products. Mesoblast's objective is to become a leading cell therapy company in the world.

What is MSB known for?

Snapshot

Public AU
Ownership
2004
Year founded
83
Employees
Melbourne, Australia
Head office
1 of 47
AU Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
Melbourne, AU

Products and/or services of Mesoblast

  • Cell therapy development and commercialisation: Mesoblast develops and commercialises cell therapy products for a range of diseases, including acute respiratory distress syndrome, chronic heart failure, and severe burns.
  • Manufacturing of cell therapy products: Mesoblast manufactures cell therapy products at its state-of-the-art manufacturing facility in Victoria, Australia.
  • Clinical trials of cell therapy products: Mesoblast conducts clinical trials of its cell therapy products to assess their safety and efficacy in humans.
  • Regulatory approval of cell therapy products: Mesoblast works with regulatory authorities around the world to obtain regulatory approval for its cell therapy products.
  • Commercialisation of cell therapy products: Mesoblast commercialises its cell therapy products to patients in need.
  • Collaboration with other companies: Mesoblast collaborates with other companies to develop and commercialise cell therapy products.

Mesoblast executive team

  • Dr. Silviu Itescu FACP, FACRA, FRACP, MBBS (Hons)Founder, CEO, MD, Chairman of Scientific Advisory Board & Executive Director
  • Dr. Eric A. Rose M.D.Chief Medical Officer & Executive Director
  • Mr. James Michael O'BrienChief Financial Officer
  • Mr. Peter T. Howard B.Sc., L.L.B.General Counsel & Corporate Executive
  • Dr. Paul J. Simmons BSc, Ph.D.Scientific Advisor to the Chief Executive Officer
  • Ms. Geraldine Storton B.Sc., M.B.A., MMSHead of Regulatory Affairs & Quality Management
  • Mr. Justin Horst B.S.Head of Manufacturing
  • Dr. Fiona See Ph.D.Senior VP & Head of Translational Research
  • Mr. Marcelo SantoroChief Commercial Officer
  • Ms. Niva Sivakumar B.Com., L.L.B.Joint Company Secretary

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.